Clinical Trial Update: MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MDMA-assisted therapy for anxiety in patients with advanced-stage cancer was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cancer

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Anxiety Disorder, Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-05